Biological drugs
Biologic therapies using monoclonal antibodies, such as Infliximab (IFX) and Adalimumab (ADM), have recently revolutionized the treatment of chronic inflammatory bowel diseases (IBD).
The optimization of biologic therapies relies on continuous monitoring: knowing blood levels helps improve clinical effectiveness and guide therapeutic decisions.
Discover Eurospital solutions for the monitoring of biologic treatment in patients with IBD.
-
Eu-Fast Reader
New all-in-one instrument designed as a stand-alone solution, characterised by intuitive software interface and integrated touchscreen display.- Biological drugs
- Calprotectin
- Pancreatic elastase
-
ADM-Fast
Lateral flow assay for the quantitative detection of Adalimumab (ADM, Humira®) in human serum and plasma.- Biological drugs
-
IFX-Fast
Lateral flow assay for the quantitative detection of Infliximab (IFX, Remicade®) in human serum and plasma.- Biological drugs